氨酸通过NKG2A:HLA-E相互作用驱动抑制CD16低NK细胞对HGSC的反应
Anna P Nicolela1,2,3, Sarah Nersesian2,4, Stacey N Lee2,4
1Department of Pathology, Dalhousie University.
Journal of leukocyte biology
|March 9, 2026
概括
卵巢癌最致命的形式,高度血清性癌 (HGSC),显示与腺相关的免疫抑制. 一种特定的NKG2A基因变异 (V5) 加剧了这种情况,影响了NK细胞的功能和治疗反应.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 代谢过程中的代谢.
背景情况:
- 高度血清性卵巢癌 (HGSC) 是一种致命的癌症,存活率很低.
- 虽然免疫细胞透,就像自然杀手 (NK) 细胞一样,表明免疫监测,但免疫逃避的机制尚不清楚.
- 腺素是一种免疫抑制代谢物,在HGSC瘤微环境中发现.
研究的目的:
- 为了研究NK细胞和HGSC中的腺素之间的相互作用.
- 了解腺如何通过HLA-E和NKG2A影响NK细胞的抑制.
- 探索特定NKG2A单核酸多态 (V5) 在腺介导的NK细胞抑制中的作用.
主要方法:
- 与NK细胞一起培养HGSC细胞系.
- 对NK细胞受体 (NKG2A) 和连接体 (HLA-E) 表达的分析.
- 对NKG2A V5单核酸多态的基因定型 (rs2734440 C).
主要成果:
- 对HGSC细胞的腺素暴露增加了HLA-E表达,抑制了NK细胞.
- 氨酸还在NK细胞上升调节NKG2A,增强抑制.
- 具有NKG2A V5同卵性基因型的NK细胞在腺的存在下表现出最深刻的抑制.
结论:
- 腺素通过调节HLA-E和NKG2A来驱动HGSC中的NK细胞免疫抑制.
- NKG2A V5变体显著放大了腺诱导的NK细胞抑制.
- KLRC1-V5变异可能作为预测对抗NKG2A疗法的反应和对腺驱动免疫抑制的敏感性的生物标志物.
相关概念视频
01:27Cytotoxic T Cells-mediated Immune Response
7.8K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.8K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
706
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
706
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K